A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia (2025)
- Authors:
- USP affiliated authors: TRAINA, FABÍOLA - FMRP ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; MACEDO, BRUNNO GILBERTO SANTOS DE - FMRP ; MELO, MANUELA ALBUQUERQUE DE - FMRP ; MARTINS, DIEGO ANTONIO PEREIRA - FMRP
- Unidades: FMRP; ICB
- DOI: https://doi.org/10.1016/j.htct.2025.103758
- Subjects: FARMACOLOGIA; LEUCEMIA MIELOIDE AGUDA; ANTINEOPLÁSICOS; MUTAÇÃO GENÉTICA; EXPRESSÃO GÊNICA; SEQUENCIAMENTO GENÉTICO; CITOCINAS; INFLAMAÇÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: São José do Rio Preto, SP
- Date published: 2025
- Source:
- Título: Hematology, Transfusion and Cell Therapy
- ISSN: 2531-1387
- Volume/Número/Paginação/Ano: v. 47, n. 2, art. 103758, 7 p., 2025
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
MACEDO, Brunno Gilberto Santos et al. A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia. Hematology, Transfusion and Cell Therapy, v. 47, n. 2, p. 7 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2025.103758. Acesso em: 04 ago. 2025. -
APA
Macedo, B. G. S., Melo, M. A. de, Pereira-Martins, D. A., Traina, F., & Machado Neto, J. A. (2025). A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia. Hematology, Transfusion and Cell Therapy, 47( 2), 7 . doi:https://doi.org/10.1016/j.htct.2025.103758 -
NLM
Macedo BGS, Melo MA de, Pereira-Martins DA, Traina F, Machado Neto JA. A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2025 ; 47( 2): 7 .[citado 2025 ago. 04 ] Available from: https://doi.org/10.1016/j.htct.2025.103758 -
Vancouver
Macedo BGS, Melo MA de, Pereira-Martins DA, Traina F, Machado Neto JA. A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2025 ; 47( 2): 7 .[citado 2025 ago. 04 ] Available from: https://doi.org/10.1016/j.htct.2025.103758 - The NLRP3 inflammasome and its role in acute myeloid leukemia onset and development
- Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia
- Autophagy induction constitutes a targetable vulnerability in FLT3-mutant acute Myeloid Leukemia cells treated with FLT3-inhibitors
- An updated outlook on autophagy mechanism and how it supports acute myeloid leukemia maintenance
- Molecular mechanisms associated with autophagy inhibition to overcome resistance to FLT3 inhibitors
- Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation
- DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients
- Stathmin 1 expression in plasma cell neoplasms. [Carta]
- IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. [Carta]
- De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
Informações sobre o DOI: https://doi.org/10.1016/j.htct.2025.103758 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
A_common_ground._An_in_si... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
